274 related articles for article (PubMed ID: 26298739)
1. Soluble klotho and mortality: the Ludwigshafen Risk and Cardiovascular Health Study.
Brandenburg VM; Kleber ME; Vervloet MG; Larsson TE; Tomaschitz A; Pilz S; Stojakovic T; Delgado G; Grammer TB; Marx N; März W; Scharnagl H
Atherosclerosis; 2015 Oct; 242(2):483-9. PubMed ID: 26298739
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor 23 (FGF23) and mortality: the Ludwigshafen Risk and Cardiovascular Health Study.
Brandenburg VM; Kleber ME; Vervloet MG; Tomaschitz A; Pilz S; Stojakovic T; Delgado G; Grammer TB; Marx N; März W; Scharnagl H
Atherosclerosis; 2014 Nov; 237(1):53-9. PubMed ID: 25200615
[TBL] [Abstract][Full Text] [Related]
3. The FGF23-Klotho axis and cardiac tissue Doppler imaging in pediatric chronic kidney disease-a prospective cohort study.
Tranæus Lindblad Y; Olauson H; Vavilis G; Hammar U; Herthelius M; Axelsson J; Bárány P
Pediatr Nephrol; 2018 Jan; 33(1):147-157. PubMed ID: 28795324
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor 23 and soluble klotho in children with chronic kidney disease.
Wan M; Smith C; Shah V; Gullet A; Wells D; Rees L; Shroff R
Nephrol Dial Transplant; 2013 Jan; 28(1):153-61. PubMed ID: 23180879
[TBL] [Abstract][Full Text] [Related]
5. Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.
Pavik I; Jaeger P; Ebner L; Wagner CA; Petzold K; Spichtig D; Poster D; Wüthrich RP; Russmann S; Serra AL
Nephrol Dial Transplant; 2013 Feb; 28(2):352-9. PubMed ID: 23129826
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor 23 and Klotho as cardiovascular risk factors in heart transplant recipients.
Przybylowski P; Wasilewski G; Janik L; Kozlowska S; Nowak E; Malyszko J
Transplant Proc; 2014 Oct; 46(8):2848-51. PubMed ID: 25380933
[TBL] [Abstract][Full Text] [Related]
7. Association of plasma aldosterone with cardiovascular mortality in patients with low estimated GFR: the Ludwigshafen Risk and Cardiovascular Health (LURIC) Study.
Tomaschitz A; Pilz S; Ritz E; Grammer T; Drechsler C; Boehm BO; März W
Am J Kidney Dis; 2011 Mar; 57(3):403-14. PubMed ID: 21186074
[TBL] [Abstract][Full Text] [Related]
8. Higher fibroblast growth factor-23 increases the risk of all-cause and cardiovascular mortality in the community.
Ärnlöv J; Carlsson AC; Sundström J; Ingelsson E; Larsson A; Lind L; Larsson TE
Kidney Int; 2013 Jan; 83(1):160-6. PubMed ID: 22951890
[TBL] [Abstract][Full Text] [Related]
9. Cystatin C is independently associated with total and cardiovascular mortality in individuals undergoing coronary angiography. The Ludwigshafen Risk and Cardiovascular Health (LURIC) study.
Woitas RP; Kleber ME; Meinitzer A; Grammer TB; Silbernagel G; Pilz S; Tomaschitz A; Weihrauch G; Dobnig H; März W; Scharnagl H
Atherosclerosis; 2013 Aug; 229(2):541-8. PubMed ID: 23706287
[TBL] [Abstract][Full Text] [Related]
10. Circulating α-klotho levels in CKD and relationship to progression.
Kim HR; Nam BY; Kim DW; Kang MW; Han JH; Lee MJ; Shin DH; Doh FM; Koo HM; Ko KI; Kim CH; Oh HJ; Yoo TH; Kang SW; Han DS; Han SH
Am J Kidney Dis; 2013 Jun; 61(6):899-909. PubMed ID: 23540260
[TBL] [Abstract][Full Text] [Related]
11. Association of serum levels of FGF23 and α-Klotho with glomerular filtration rate and proteinuria among cardiac patients.
Ozeki M; Fujita S; Kizawa S; Morita H; Sohmiya K; Hoshiga M; Ishizaka N
BMC Nephrol; 2014 Sep; 15():147. PubMed ID: 25200959
[TBL] [Abstract][Full Text] [Related]
12. Long-term sevelamer treatment lowers serum fibroblast growth factor 23 accompanied with increasing serum Klotho levels in chronic haemodialysis patients.
Lin HH; Liou HH; Wu MS; Lin CY; Huang CC
Nephrology (Carlton); 2014 Nov; 19(11):672-8. PubMed ID: 25113414
[TBL] [Abstract][Full Text] [Related]
13. Homoarginine, cardiovascular risk, and mortality.
März W; Meinitzer A; Drechsler C; Pilz S; Krane V; Kleber ME; Fischer J; Winkelmann BR; Böhm BO; Ritz E; Wanner C
Circulation; 2010 Sep; 122(10):967-75. PubMed ID: 20733103
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil gelatinase-associated lipocalin levels are U-shaped in the Ludwigshafen Risk and Cardiovascular Health (LURIC) study-Impact for mortality.
Woitas RP; Scharnagl H; Kleber ME; Delgado GE; Grammer TB; Pichler M; Krämer BK; März W; Stojakovic T
PLoS One; 2017; 12(2):e0171574. PubMed ID: 28207778
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast growth factor 23 is not associated with and does not induce arterial calcification.
Scialla JJ; Lau WL; Reilly MP; Isakova T; Yang HY; Crouthamel MH; Chavkin NW; Rahman M; Wahl P; Amaral AP; Hamano T; Master SR; Nessel L; Chai B; Xie D; Kallem RR; Chen J; Lash JP; Kusek JW; Budoff MJ; Giachelli CM; Wolf M;
Kidney Int; 2013 Jun; 83(6):1159-68. PubMed ID: 23389416
[TBL] [Abstract][Full Text] [Related]
16. Gender Specific Association between Serum Fibroblast Growth Factor 23/α-Klotho and Coronary Artery and Aortic Valve Calcification.
Morita H; Takeda Y; Fujita S; Okamoto Y; Sakane K; Teramoto K; Ozeki M; Tasaki R; Kizawa S; Sohmiya K; Hoshiga M; Ishizaka N
J Atheroscler Thromb; 2015; 22(12):1338-46. PubMed ID: 26279337
[TBL] [Abstract][Full Text] [Related]
17. Circulating Klotho Associates With Cardiovascular Morbidity and Mortality During Hemodialysis.
Marçais C; Maucort-Boulch D; Drai J; Dantony E; Carlier MC; Blond E; Genet L; Kuentz F; Lataillade D; Legrand E; Moreau-Gaudry X; Jean G; Fouque D;
J Clin Endocrinol Metab; 2017 Sep; 102(9):3154-3161. PubMed ID: 28402487
[TBL] [Abstract][Full Text] [Related]
18. Soluble α-klotho and its relation to kidney function and fibroblast growth factor-23.
Scholze A; Liu Y; Pedersen L; Xia S; Roth HJ; Hocher B; Rasmussen LM; Tepel M
J Clin Endocrinol Metab; 2014 May; 99(5):E855-61. PubMed ID: 24606097
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor 23 and Klotho serum levels in healthy children.
Gkentzi D; Efthymiadou A; Kritikou D; Chrysis D
Bone; 2014 Sep; 66():8-14. PubMed ID: 24880094
[TBL] [Abstract][Full Text] [Related]
20. Uric acid is predictive of cardiovascular mortality and sudden cardiac death in subjects referred for coronary angiography.
Silbernagel G; Hoffmann MM; Grammer TB; Boehm BO; März W
Nutr Metab Cardiovasc Dis; 2013 Jan; 23(1):46-52. PubMed ID: 21703834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]